| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |